Elanix Biotechnologies AG

DUSE:ELN Stock Report

Market Cap: €428.3k

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Elanix Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ELN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,729,16721.4%
General Public6,351,73578.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 1 shareholders own 21.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.4%
Marco Christen
1,729,167€91.6k0%no data